VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.05	19.93	30.62	30.91	42.25	57.56
Short-Term Investments	17.6	41.59	62.63	-	-	1.03
Cash & Short-Term Investments	39.65	61.52	93.25	30.91	42.25	58.59
Cash Growth	-49.24%	-34.03%	201.71%	-26.85%	-27.89%	106.68%
Accounts Receivable	-	-	-	-	7.58	15.82
Other Receivables	-	-	-	5	-	-
Total Trade Receivables	-	-	-	5	7.58	15.82
Inventory	-	-	-	-	-	7.4
Other Current Assets	4.7	2.92	2.71	2.37	13.02	5.45
Total Current Assets	44.34	64.44	95.96	38.28	63.19	87.26
Net Property, Plant & Equipment	0.13	0.21	0.21	-	0.69	2.14
Other Long-Term Assets	0.24	2.26	1.52	2.48	3.51	4.35
Total Assets	44.72	66.91	97.69	40.76	67.05	93.74
Accounts Payable	1.41	2.71	1.66	2.39	6.51	4.78
Accrued Expenses	0.82	1.43	1.65	2.58	2.96	4.67
Current Portion of Leases	0.03	0.1	0.12	-	0.35	0.76
Other Current Liabilities	-	1.31	-	-	-	0.1
Total Current Liabilities	5.84	14.82	7.54	9.35	9.82	21.77
Long-Term Debt	-	-	-	-	-	33.17
Long-Term Leases	-	-	0.1	-	-	0.85
Other Long-Term Liabilities	-	-	1.31	-	-	0.46
Total Long-Term Liabilities	-	-	1.41	-	-	34.48
Total Liabilities	5.84	14.82	8.95	9.35	18.41	56.25
Preferred Stock	-	-	-	0.21	-	-
Common Stock	0	0	0	0	0.01	0
Additional Paid-in Capital	784.42	783.24	780.04	693.94	688.16	603.69
Accumulated Other Comprehensive Income	-0	0.02	0.03	-	-	-
Retained Earnings	-745.54	-731.17	-691.34	-662.74	-639.53	-566.2
Total Common Shareholders' Equity	38.88	52.09	88.74	31.41	48.64	37.49
Shareholders' Equity	38.88	52.09	88.74	31.2	48.64	37.49
Total Liabilities & Equity	44.72	66.91	97.69	40.76	67.05	93.74
Total Debt	0.03	0.1	0.21	0	0.35	34.78
Net Cash (Debt)	39.62	61.42	93.04	30.91	41.9	23.81
Net Cash Growth	-35.49%	-33.99%	201.02%	-26.24%	76.01%	-
Net Cash Per Share	0.93	1.44	9.06	9.70	14.66	13.22
Book Value	38.88	52.09	88.74	31.41	48.64	37.49
Book Value Per Share	0.91	1.22	8.64	9.86	17.01	20.82
Tangible Book Value	38.88	52.09	88.74	31.41	48.64	37.49
Tangible Book Value Per Share	0.91	1.22	8.64	9.86	17.01	20.82

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q